Skip to main content
Login | Suomeksi | På svenska | In English

68Ga-Labeled radiopharmaceuticals for pretargeted PET imaging : synthesis of 68Ga-HBED-CC-tetrazines

Show simple item record 2017-11-14T11:03:02Z 2017-11-14T11:03:02Z 2017-11-14
dc.title 68Ga-Labeled radiopharmaceuticals for pretargeted PET imaging : synthesis of 68Ga-HBED-CC-tetrazines en
ethesis.discipline Radiochemistry en
ethesis.discipline Radiokemia fi
ethesis.discipline Radiokemi sv
ethesis.department Kemiska institutionen sv
ethesis.department Department of Chemistry en
ethesis.department Kemian laitos fi
ethesis.faculty Matematisk-naturvetenskapliga fakulteten sv
ethesis.faculty Faculty of Science en
ethesis.faculty Matemaattis-luonnontieteellinen tiedekunta fi
ethesis.faculty.URI Helsingfors universitet sv University of Helsinki en Helsingin yliopisto fi
dct.creator Honkaniemi, Elina
dct.issued 2017
dct.language.ISO639-2 eng
dct.abstract An extremely high demand of 68Ga-radiotracers has ascended during the last decade in the field of nuclear medicine. 68Ga is a positron emitting radionuclide which is widely used in positron emission tomography (PET) studies due to its short half-live of 68 minutes and good labeling properties. 68Ga can be produced on site using 68Ge/68Ga-generator which makes it a viable option in comparison to the cyclotron-based PET isotopes such as 18F. Gallium’s coordination chemistry demands it to be coordinated with a ligand for it to be stable enough to be introduced to target peptide. For that reason, chelating agents are commonly used to stabilize gallium, such as DOTA, NOTA or TRAP. Major of the chelators are bifunctional which means they can also bind to the target biomolecule such as peptide or antibody. Tetrazine molecule is widely used in bioorthogonal cycloaddition reactions in live cell labeling. Bioorthogonal reactions are used in pretargeting approach where first the unlabeled antibody is administrated to localize the tumour and after that, small rapid-clearing radiolabeled compound is injected to attach to the antibody. In this work, bifunctional chelating agent HBED-CC was first coupled with tetrazine and after successful synthesis, the compound was labeled with 68Ga. Aim of the study was to discover the potential of this compound to pass the cell membrane and to determinate its properties. The synthesis of HBED-CC-tetrazine was successfully optimized with good yields in a range of 65-85 %. Different synthesis conditions were tested including temperature, reaction time and the choice of a coupling reagent. Optimized conditions for the synthesis of HBED-CC-tetrazine were 48 hours in room temperature using the coupling reagent HATU. Radiosynthesis of [68Ga] Ga-HBED-CC-tetrazine was also optimized using different temperatures, reaction times and precursor amounts. All conditions resulted in good radiochemical yields. Optimized conditions for radiolabeling turned out to be in 85 degrees for 20 minutes which resulted in 97 % of radiochemical yield with over 98 % radiochemical purity. The properties of the labeled compound [68Ga] Ga-HBED-CC-tetrazine were tested, such as lipophilicity and the stability of the compound in a presence of iron. en
dct.language en
ethesis.isPublicationLicenseAccepted true
ethesis.language English en
ethesis.language englanti fi
ethesis.language engelska sv
ethesis.thesistype pro gradu-avhandlingar sv
ethesis.thesistype pro gradu -tutkielmat fi
ethesis.thesistype master's thesis en
dct.identifier.ethesis E-thesisID:86ca4aaa-2144-4fbb-986e-c4a0f4b228c8
dct.identifier.urn URN:NBN:fi-fe2017112252525
dc.type.dcmitype Text

Files in this item

Files Size Format View
Gradu_ElinaHonkaniemi.pdf 1.164Mb PDF

This item appears in the following Collection(s)

Show simple item record